To investigate whether irradiated volume of pelvic active bone marrow (ACTBM) may predict decreased blood cells nadirs in anal cancer patients undergoing concurrent chemo-radiation.

Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation

Franco, Pierfrancesco
First
;
Arcadipane, Francesca;Lesca, Adriana;Gallio, Elena;Mistrangelo, Massimiliano;Trino, Elisabetta;Cassoni, Paola;Arena, Vincenzo;Faletti, Riccardo;Morino, Mario;Ricardi, Umberto
Last
2018

Abstract

To investigate whether irradiated volume of pelvic active bone marrow (ACTBM) may predict decreased blood cells nadirs in anal cancer patients undergoing concurrent chemo-radiation.
36
5
279
288
Anal cancer; Bone marrow; Concomitant radiochemotherapy; Hematologic toxicity; IMRT; PET; Radiotherapy
Franco, Pierfrancesco; Arcadipane, Francesca; Ragona, Riccardo; Lesca, Adriana; Gallio, Elena; Mistrangelo, Massimiliano; Trino, Elisabetta; Cassoni, Paola; Arena, Vincenzo; Baccega, Massimo; Racca, Patrizia; Faletti, Riccardo; Rondi, Nadia; Morino, Mario; Ricardi, Umberto
File in questo prodotto:
File Dimensione Formato  
Dose to Pelvic Bone Marrow Defined with FDG PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo radiation.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.48 MB
Formato Adobe PDF
1.48 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1670181
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact